ColdAI, founded in 2023, operates in the rapidly evolving fields of AI, Information Technology, and Machine Learning. Positioned in the United States, this company is making waves while maintaining a Stealth Mode approach.
With its intriguing slogan, "Medical Technology with focus on Brain to Computer Interfaces (BCI) working with AI to improve the human condition," ColdAI is clearly targeting the frontier of human-machine integration. Its focus on Brain to Computer Interfaces (BCI) suggests potential applications in both healthcare and consumer tech.
Having secured a $150.00K Pre Seed Round investment in August 2023, ColdAI appears poised to leverage its cutting-edge expertise to carve out a significant niche in the market. Although details of its investors have not been disclosed, the company's ability to attract investment in a stealth phase signals a compelling value proposition.